Navigation Links
Thoratec Announces Filing of PMA Seeking Destination Therapy Approval for HeartMate II(R)
Date:4/20/2009

PLEASANTON, Calif., April 20 /PRNewswire-FirstCall/ -- Thoratec Corporation (Nasdaq: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, said today that it has filed a PMA (Pre-Market Approval) supplement with the FDA seeking to add the intended use of Destination Therapy (DT) for the HeartMate II LVAS (left ventricular assist system). The HeartMate II is a next generation heart assist device designed to provide long-term cardiac support for patients suffering from advanced stage heart failure. The device was approved for Bridge-to-Transplantation (BTT) in the U.S. under the original PMA in April 2008.

The PMA filing includes data on a pivotal study cohort of 200 randomized patients, including two-year data on the first 167 patients enrolled. Also included in the primary analysis are data on 24 small BSA (body surface area) patients who because of their body size could not be randomized to the larger HeartMate XVE. The filing also provides data on adjunctive cohorts totaling an additional 409 patients, including those who had been originally supported by an XVE who then elected to receive a HeartMate II, based on the need for device replacement, and patients enrolled under Continuous Access Protocols (CAPs). The company plans to file an amendment to the PMA supplement submission with complete two-year data on all 200 randomized patients at the end of June.

"We are pursuing this approach and making this submission at this time based on a series of discussions with the FDA. An interim analysis conducted at the end of 2008 for the primary endpoint demonstrated statistically significant superiority in favor of the HeartMate II versus the control group. As a result, Thoratec and the FDA have agreed that it is appropriate to make this filing now and to then file
'/>"/>

SOURCE Thoratec Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Thoratec Announces HeartMate II(R) PMA Will be Reviewed by FDA Advisory Panel
2. Thoratec Presentation at Bear Stearns Conference To Be Webcast
3. Thoratec Announces Appointment of Steven H. Collis to Board of Directors
4. Thoratec Presentation at JP Morgan Conference to be Webcast
5. Thoratec Reports 10 Percent Increase in Fiscal 2007 Revenues; Fourth Quarter Revenues Largest in Company History
6. Thoratec Schedules Third Quarter 2008 Conference Call, Webcast
7. Thoratec Reports 44 Percent Increase in Third Quarter Revenues
8. Thoratec Presentation at J.P. Morgan Conference to be Webcast
9. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
10. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
11. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... JOSE, California , January 15, 2014 ... cancer, today announced the appointment of Thomas C Reynolds MD, ... 20 years, development experience gained in the biotechnology industry, most ... "I am delighted to welcome Tom at this transformative time ...
(Date:1/15/2014)... Reston, VA (PRWEB) January 15, 2014 ... education have continued their sponsorship of an annual competition ... interest in, and access to, innovative STEM study. The ... , TEAMS: Tests of Engineering Aptitude, Mathematics, and ...
(Date:1/15/2014)... AudioNotch is the internet's leading provider of ... of tinnitus. Patients listen to sound therapy that is ... of weeks to months, their tinnitus volume decreases. , AudioNotch ... Music and Notched White Noise. Now, AudioNotch is pleased to ...
(Date:1/14/2014)... , Jan. 14, 2014  3D Communications, a leading provider of ... regulatory, business, and media events in the United States ... former associate Virginia Cox , JD, is returning to the ... Virginia Cox re-joins 3D after more than two years of ...
Breaking Biology Technology:Oxford BioTherapeutics Appoints Thomas C Reynolds MD, PhD to its Board of Directors 2Oxford BioTherapeutics Appoints Thomas C Reynolds MD, PhD to its Board of Directors 3Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 2Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 3Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 4Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 5Former FDA Associate Commissioner Returns To 3D Communications 2
... Wis. - Building the Merge Healthcare ... explains, will mean offshoring 150 jobs to a "more ... reduce 28 percent of the financially troubled medical imaging ... Japan to regain the competitive edge marks the centerpiece ...
... people, a natural biological response to the phrase securities law ... the outside of the cornea wall, coupled with a dull ... my best to stick to the essentials. As a result, ... company is raising capital, it is important to contact an ...
... Wisconsin organizers of Make Mine a $Million ... May as Wisconsin does its part to take one ... , ,Although the date of the awards program has ... including Make Mine a $Million members - soon will ...
Cached Biology Technology:Merge offshoring jobs to "more cost-effective" workforce 2Merge offshoring jobs to "more cost-effective" workforce 3Securities compliance is part of raising capital 2Securities compliance is part of raising capital 3Securities compliance is part of raising capital 4Make Mine a $Million shoots for May program 2Make Mine a $Million shoots for May program 3
(Date:7/9/2014)... an associate professor of plant pathology and microbiology ... awarded the 2014 Alexopoulos Prize by the ... advancing the science of mycology the study of ... lichens, plant pathogens, and medically important fungi. , The ... early-career mycologist. Stajich received the award last month in ...
(Date:7/9/2014)... Research Centre (CNIO) have discovered that NANOG, an essential ... in stratified epitheliathose that form part of the epidermis ... vaginain adult organisms. According to the conclusions of the ... this factor could also play a role in the ... oesophagus and skin. , The pluripotency factor NANOG is ...
(Date:7/9/2014)... the puzzle behind nature,s ability to split the ... the development of artificial photosynthesis for clean, green ... international collaboration of scientists led by researchers with ... the SLAC National Accelerator Laboratory. , Working ... world,s most powerful x-ray laser, the researchers were ...
Breaking Biology News(10 mins):UC Riverside plant pathologist receives national recognition 2CNIO scientists discover that pluripotency factor NANOG is also active in adult organisms 2Postcards from the photosynthetic edge 2Postcards from the photosynthetic edge 3
... of Technology have created a new sampling device that ... pneumonia each year. Called PneumoniaCheck, the device created ... of diagnosing pneumonia, which is a major initiative of ... Pneumonia, an inflammation of the lungs, kills about ...
... a method based on geographic positioning systems that allowed ... in a way similar to how geographers characterize mountain ... that reflects how "rugged" the surface of the tooth ... the shearing molars in insect eaters and omnivores to ...
... 18, 2011) -- A University of Arizona College of ... robots for planetary exploration will be featured in a ... "WaveLengths." The robots will be featured on the ... MST on public television KUAT Channel 6. "WaveLengths" is ...
Cached Biology News:A better way to diagnose pneumonia 2A better way to diagnose pneumonia 3UMass Amherst biologists use GPS to 'map' bats teeth to explore evolutionary adaptations to diet 2Planetary exploration robots to be featured on science program 'WaveLengths' 2